BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

216 related articles for article (PubMed ID: 25815755)

  • 1. Post-SSRI Sexual Dysfunction: Clinical Characterization and Preliminary Assessment of Contributory Factors and Dose-Response Relationship.
    Ben-Sheetrit J; Aizenberg D; Csoka AB; Weizman A; Hermesh H
    J Clin Psychopharmacol; 2015 Jun; 35(3):273-8. PubMed ID: 25815755
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Post-SSRI Sexual Dysfunction: A Literature Review.
    Bala A; Nguyen HMT; Hellstrom WJG
    Sex Med Rev; 2018 Jan; 6(1):29-34. PubMed ID: 28778697
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Exposure to serotonin selective reuptake inhibitors or serotonin noradrenaline reuptake inhibitors and sexual dysfunction: Results from an online survey.
    Patacchini A; Cosci F
    Int J Risk Saf Med; 2021; 32(3):229-242. PubMed ID: 33579876
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Post-SSRI Sexual Dysfunction (PSSD): Biological Plausibility, Symptoms, Diagnosis, and Presumed Risk Factors.
    Peleg LC; Rabinovitch D; Lavie Y; Rabbie DM; Horowitz I; Fruchter E; Gruenwald I
    Sex Med Rev; 2022 Jan; 10(1):91-98. PubMed ID: 34627736
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Characterizing post-SSRI sexual dysfunction and its impact on quality of life through an international online survey.
    Studt A; Gannon M; Orzel J; Vaughan A; Pearlman AM
    Int J Risk Saf Med; 2021; 32(4):321-329. PubMed ID: 34366299
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Sexual Consequences of Post-SSRI Syndrome.
    Reisman Y
    Sex Med Rev; 2017 Oct; 5(4):429-433. PubMed ID: 28642048
    [TBL] [Abstract][Full Text] [Related]  

  • 7. An open-label study to evaluate switching from an SSRI or SNRI to tiagabine to alleviate antidepressant-induced sexual dysfunction in generalized anxiety disorder.
    Schwartz TL; Nasra GS; Ashton AK; Kang D; Kumaresan H; Chilton M; Bertone F
    Ann Clin Psychiatry; 2007; 19(1):25-30. PubMed ID: 17453658
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Selective serotonin reuptake inhibitors, post-treatment sexual dysfunction and persistent genital arousal disorder: A systematic review.
    Tarchi L; Merola GP; Baccaredda-Boy O; Arganini F; Cassioli E; Rossi E; Maggi M; Baldwin DS; Ricca V; Castellini G
    Pharmacoepidemiol Drug Saf; 2023 Oct; 32(10):1053-1067. PubMed ID: 37294623
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Genital anaesthesia persisting six years after sertraline discontinuation.
    Bolton JM; Sareen J; Reiss JP
    J Sex Marital Ther; 2006; 32(4):327-30. PubMed ID: 16709553
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Trazodone for the treatment of sexual dysfunction induced by serotonin reuptake inhibitors: a preliminary open-label study.
    Stryjer R; Spivak B; Strous RD; Shiloh R; Harary E; Polak L; Birgen M; Kotler M; Weizman A
    Clin Neuropharmacol; 2009; 32(2):82-4. PubMed ID: 18978492
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The pathophysiology of Post SSRI Sexual Dysfunction - Lessons from a case study.
    Klaas S; Siva JB; Bak M; Govers M; Schreiber R
    Biomed Pharmacother; 2023 May; 161():114166. PubMed ID: 36898260
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Persistent sexual dysfunction after SSRI withdrawal: a scoping review and presentation of 86 cases from the Netherlands.
    Chinchilla Alfaro K; van Hunsel F; Ekhart C
    Expert Opin Drug Saf; 2022 Apr; 21(4):553-561. PubMed ID: 34791958
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Towards Improving Post-SSRI Sexual Dysfunction by Using Nutriceuticals: Lessons from a Case Study.
    Calabrò RS; De Luca R; Manuli A; Portaro S; Naro A; Quattrini F
    J Sex Marital Ther; 2019; 45(6):562-565. PubMed ID: 30640584
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Summary of findings from the FDA regulatory science forum on measuring sexual dysfunction in depression trials.
    Kronstein PD; Ishida E; Khin NA; Chang E; Hung HM; Temple RJ; Yang P
    J Clin Psychiatry; 2015 Aug; 76(8):1050-9. PubMed ID: 26335083
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A clinical review of antidepressants, their sexual side-effects, post-SSRI sexual dysfunction, and serotonin syndrome.
    Marks S
    Br J Nurs; 2023 Jul; 32(14):678-682. PubMed ID: 37495413
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Post-finasteride syndrome and post-SSRI sexual dysfunction: two sides of the same coin?
    Giatti S; Diviccaro S; Panzica G; Melcangi RC
    Endocrine; 2018 Aug; 61(2):180-193. PubMed ID: 29675596
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Genome-wide association study of SSRI/SNRI-induced sexual dysfunction in a Japanese cohort with major depression.
    Kurose K; Hiratsuka K; Ishiwata K; Nishikawa J; Nonen S; Azuma J; Kato M; Wakeno M; Okugawa G; Kinoshita T; Kurosawa T; Hasegawa R; Saito Y
    Psychiatry Res; 2012 Aug; 198(3):424-9. PubMed ID: 22445761
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Sexual dysfunction with antidepressive agents. Effect of the change to amineptine in patients with sexual dysfunction secondary to SSRI].
    Montejo AL; Llorca G; Izquierdo JA; Carrasco JL; Daniel E; Pérez-Sola V; Vicens E; Bousoño M; Sánchez-Iglesias S; Franco M; Cabezudo A; Rubio V; Ortega MA; Puigdellivol M; Domenech JR; Allué B; Sáez C; Mezquita B; Gálvez I; Pacheco L; de Miguel E
    Actas Esp Psiquiatr; 1999; 27(1):23-34. PubMed ID: 10380144
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Comparison of adjunctive use of aripiprazole with bupropion or selective serotonin reuptake inhibitors/serotonin-norepinephrine reuptake inhibitors: analysis of patients beginning adjunctive treatment in a 52-week, open-label study.
    Clayton AH; Baker RA; Sheehan JJ; Cain ZJ; Forbes RA; Marler SV; Marcus R; Berman RM; Thase ME
    BMC Res Notes; 2014 Jul; 7():459. PubMed ID: 25037144
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Post-SSRI sexual dysfunction: Patient experiences of engagement with healthcare professionals.
    Healy D; Le Noury J; Mangin D
    Int J Risk Saf Med; 2019; 30(3):167-178. PubMed ID: 31450514
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.